Ightm1(Myc)Janz/Igh+ Mdm4tm1.1Wahl/Mdm4tm1.1Wahl
involves: 129S/Sv * C57BL/6
|
enlarged liver |
J:150341
|
enlarged lymph nodes |
J:150341
|
enlarged spleen |
J:150341
|
increased B cell derived lymphoma incidence |
J:150341
|
increased lymphoma incidence |
J:150341
|
increased splenocyte proliferation |
J:150341
|
premature death |
J:150341
|
Mdm2tm1Glo/Mdm2+ Mdm4Gt(VICTR20)7Lex/Mdm4+ Trp53tm1Wahl/Trp53tm1Wahl
involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6
|
abnormal cell cycle |
J:108183
|
Mdm2tm1Glo/Mdm2+ Mdm4Gt(VICTR20)7Lex/Mdm4+ Trp53tm3Wahl/Trp53tm3Wahl
involves: 129
|
abnormal cell cycle |
J:108183
|
Mdm2tm1Glo/Mdm2+ Mdm4tm1Glo/Mdm4+
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6
|
abnormal cell physiology |
J:123661
|
abnormal cerebellar granule layer morphology |
J:123661
|
abnormal cerebellum external granule cell layer morphology |
J:123661
|
abnormal definitive hematopoiesis |
J:123661
|
abnormal Purkinje cell morphology |
J:123661
|
anemia |
J:123661
|
cerebellum hypoplasia |
J:123661
|
cleft palate |
J:123661
|
decreased body weight |
J:123661
|
decreased bone marrow cell number |
J:123661
|
decreased embryo size |
J:123661
|
decreased erythrocyte cell number |
J:123661
|
decreased fetal size |
J:123661
|
decreased hemoglobin content |
J:123661
|
decreased leukocyte cell number |
J:123661
|
decreased renal glomerulus number |
J:123661
|
exencephaly |
J:123661
|
increased embryonic tissue cell apoptosis |
J:123661
|
kinked tail |
J:123661
|
pallor |
J:123661
|
pancytopenia |
J:123661
|
postnatal lethality, complete penetrance |
J:123661
|
prenatal lethality, incomplete penetrance |
J:123661
|
spleen atrophy |
J:123661
|
spleen hypoplasia |
J:123661
|
thrombocytopenia |
J:123661
|
thymus atrophy |
J:123661
|
thymus hypoplasia |
J:123661
|
Mdm2tm1Glo/Mdm2+ Mdm4tm1Glo/Mdm4+
involves: 129S7/SvEvBrd
|
abnormal Purkinje cell morphology |
J:174216
|
anemia |
J:174216
|
decreased bone marrow cell number |
J:174216
|
decreased cerebellar granule cell number |
J:174216
|
increased foot pad pigmentation |
J:174216
|
normal
mortality/aging |
J:71532
|
small cerebellum |
J:174216
|
Mdm2tm1Glo/Mdm2+ Mdm4tm1Glo/Mdm4+ Trp53tm1Tyj/Trp53+
involves: 129S2/SvPas * 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6
|
normal
mortality/aging |
J:123661
|
Mdm2tm1Glo/Mdm2+ Mdm4tm2.1Glo/Mdm4+
involves: 129S7/SvEvBrd
|
increased foot pad pigmentation |
J:174216
|
Mdm4Gt(VICTR20)7Lex/Mdm4+ Trp53tm1Wahl/Trp53tm1Wahl
involves: 129S5/SvEvBrd * C57BL/6
|
abnormal cell cycle |
J:108183
|
Mdm4Gt(VICTR20)7Lex/Mdm4+ Trp53tm1.1Xlu/Trp53tm1.1Xlu
involves: 129S5/SvEvBrd * 129S6/SvEvTac * C57BL/6 * FVB/N
|
abnormal embryo development |
J:166152
|
embryonic growth retardation |
J:166152
|
embryonic lethality during organogenesis, incomplete penetrance |
J:166152
|
Mdm4Gt(VICTR20)7Lex/Mdm4Gt(VICTR20)7Lex Trp53tm1.1Xlu/Trp53tm1.1Xlu
involves: 129S5/SvEvBrd * 129S6/SvEvTac * C57BL/6 * FVB/N
|
normal
cellular phenotype |
J:166152
|
embryonic lethality during organogenesis, incomplete penetrance |
J:166152
|
Mdm4Gt(VICTR20)7Lex/Mdm4Gt(VICTR20)7Lex Trp53tm1Tyj/Trp53+
involves: 129S2/SvPas * 129S5/SvEvBrd
|
decreased embryo size |
J:77907
|
preweaning lethality, complete penetrance |
J:77907
|
Mdm4Gt(VICTR20)7Lex/Mdm4Gt(VICTR20)7Lex Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * 129S5/SvEvBrd
|
abnormal cell cycle checkpoint function |
J:77907
|
decreased cellular sensitivity to ultraviolet irradiation |
J:77907
|
normal
embryo phenotype |
J:77907
|
increased fibroblast proliferation |
J:77907
|
normal
mortality/aging |
J:77907
|
Mdm4Gt(VICTR20)7Lex/Mdm4Gt(VICTR20)7Lex Trp53tm1Wahl/Trp53tm1Wahl
involves: 129S5/SvEvBrd * C57BL/6
|
abnormal cell cycle |
J:108183
|
decreased cell proliferation |
J:108183
|
Mdm4Gt(VICTR20)7Lex/Mdm4Gt(VICTR20)7Lex Trp53tm3Wahl/Trp53tm3Wahl
involves: 129S4/SvJae * 129S5/SvEvBrd
|
abnormal cell cycle |
J:108183
|
decreased fibroblast proliferation |
J:108183
|
normal
mortality/aging |
J:108183
|
Mdm4tm1Glo/Mdm4+ Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6
|
normal
mortality/aging |
J:123661
|
Mdm4tm1Glo/Mdm4+ Tg(IghMyc)22Bri/0
involves: 129S6/SvEvTac * C57BL * C57BL/6 * SJL
|
increased B cell derived lymphoma incidence |
J:123661
|
Mdm4tm1Glo/Mdm4+ Rpl27aSfa/Rpl27a+
involves: C57BL/6J
|
prenatal lethality, complete penetrance |
J:174216
|
Mdm4tm1Glo/Mdm4+ Trp53tm1.1Tldo/Trp53+
involves: 129S2/SvPas * BALB/c * C57BL/6
|
decreased bone marrow cell number |
J:199308
|
decreased telomere length |
J:199308
|
premature death |
J:199308
|
Mdm4tm1Glo/Mdm4tm1Glo Trp53tm1Adv/Trp53tm1Adv
involves: 129S4/SvJae
|
abnormal embryo development |
J:93838
|
embryonic growth retardation |
J:93838
|
preweaning lethality, complete penetrance |
J:93838
|
Mdm4tm1Glo/Mdm4tm1Glo Trp53tm1Tyj/Trp53+
involves: 129S2/SvPas
|
abnormal embryo development |
J:93838
|
preweaning lethality, complete penetrance |
J:93838
|
Mdm4tm1Glo/Mdm4tm1Glo Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas
|
normal
mortality/aging |
J:71532,
J:93838
|
Mdm4tm1Zmy/Mdm4tm1Zmy Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * C57BL/6
|
no abnormal phenotype detected |
J:174359
|
Mdm4tm2.1Glo/Mdm4tm2.1Glo Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6J
|
no abnormal phenotype detected |
J:104114
|
Mdm4tm2Glo/Mdm4tm2.1Glo Tg(Myh6-cre)2182Mds/0 Trp53tm1Tyj/Trp53+
involves: 129S2/SvPas * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * FVB/N
|
extended life span |
J:137114
|
Mdm4tm2Glo/Mdm4tm2.1Glo Tg(Myh6-cre)2182Mds/0 Trp53tm1Tyj/Trp53tm1Brn
involves: 129P2/OlaHsd * 129S/Sv * C57BL/6J * FVB/N
|
normal
cardiovascular system phenotype |
J:137114
|
decreased tumor-free survival time |
J:137114
|
extended life span |
J:137114
|
increased tumor incidence |
J:137114
|
Mdm4tm3.1Glo/Mdm4+
involves: 129S6/SvEvTac * C57BL/6 * FVB/N
|
normal
mortality/aging |
J:174368
|
Mdm4tm3.1Glo/Mdm4tm3.1Glo
involves: 129S6/SvEvTac * C57BL/6 * FVB/N
|
embryonic lethality during organogenesis, complete penetrance |
J:174368
|
Mdm4tm3.1Glo/Mdm4tm3.1Glo Trp53tm3.1Glo/Trp53tm3.1Glo
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N
|
normal
mortality/aging |
J:174368
|
Mdm4tm3.1Glo/Mdm4tm3.1Glo Trp53tm4Glo/Trp53tm4Glo
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N
|
normal
mortality/aging |
J:174368
|
Mdm4tm3Glo/Mdm4tm3.1Glo Tg(CAG-cre/Esr1*)5Amc/0
involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N
|
no abnormal phenotype detected |
J:174368
|